ZA201001125B - Pyrrolidine Aryl-Ether as NK3 receptor antagonists - Google Patents
Pyrrolidine Aryl-Ether as NK3 receptor antagonistsInfo
- Publication number
- ZA201001125B ZA201001125B ZA201001125A ZA201001125A ZA201001125B ZA 201001125 B ZA201001125 B ZA 201001125B ZA 201001125 A ZA201001125 A ZA 201001125A ZA 201001125 A ZA201001125 A ZA 201001125A ZA 201001125 B ZA201001125 B ZA 201001125B
- Authority
- ZA
- South Africa
- Prior art keywords
- ether
- receptor antagonists
- pyrrolidine
- aryl
- pyrrolidine aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07114790 | 2007-08-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201001125B true ZA201001125B (en) | 2010-10-27 |
Family
ID=39870345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA201001125A ZA201001125B (en) | 2007-08-22 | 2010-02-16 | Pyrrolidine Aryl-Ether as NK3 receptor antagonists |
Country Status (18)
Country | Link |
---|---|
US (1) | US7812021B2 (xx) |
EP (1) | EP2190815B1 (xx) |
JP (1) | JP2010536818A (xx) |
KR (1) | KR101194467B1 (xx) |
CN (1) | CN101861302A (xx) |
AR (1) | AR067991A1 (xx) |
AT (1) | ATE519738T1 (xx) |
AU (1) | AU2008290634B2 (xx) |
BR (1) | BRPI0815674A2 (xx) |
CA (1) | CA2697325A1 (xx) |
CL (1) | CL2008002450A1 (xx) |
ES (1) | ES2369955T3 (xx) |
MX (1) | MX2010001774A (xx) |
PE (1) | PE20090621A1 (xx) |
RU (1) | RU2010108687A (xx) |
TW (1) | TW200916462A (xx) |
WO (1) | WO2009024502A1 (xx) |
ZA (1) | ZA201001125B (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8063075B2 (en) * | 2008-06-10 | 2011-11-22 | Hoffmann-La Roche Inc. | Pyrrolidine ether derivatives as NK3 receptor antagonists |
MX2011003312A (es) * | 2008-10-09 | 2011-04-26 | Hoffmann La Roche | Derivados de pirrolidina n-bencilo. |
CN102282139B (zh) | 2009-01-30 | 2014-06-18 | 弗·哈夫曼-拉罗切有限公司 | 作为nk3受体拮抗剂的哌啶衍生物 |
US8318759B2 (en) * | 2009-02-18 | 2012-11-27 | Hoffmann-La Roche Inc. | Pyrrolidine derivatives as NK3 receptor antagonists |
SA110310332B1 (ar) | 2009-05-01 | 2013-12-10 | Astrazeneca Ab | مركبات ميثانون (3 استبدال -ازيتيدين -1-يل )(5- فينيل -1، 3، 4- أوكساديازول -2-يل ) |
US8394834B2 (en) * | 2009-08-25 | 2013-03-12 | Hoffman-La Roche Inc. | Pyrrolidines as NK3 receptor antagonists |
US20110144081A1 (en) * | 2009-12-15 | 2011-06-16 | Henner Knust | Pyrrolidine derivatives |
US20110152233A1 (en) | 2009-12-18 | 2011-06-23 | Henner Knust | Pyrrolidine compounds |
MX2012015102A (es) | 2010-07-06 | 2013-05-01 | Astrazeneca Ab | Agentes terapeuticos 976. |
US8507535B2 (en) | 2010-07-07 | 2013-08-13 | Hoffmann-La Roche Inc. | Methyl-pyrrolidine ether derivatives |
US8618303B2 (en) * | 2011-01-07 | 2013-12-31 | Hoffmann-La Roche Inc. | Pyrrolidine derivatives |
UY34194A (es) | 2011-07-15 | 2013-02-28 | Astrazeneca Ab | ?(3-(4-(espiroheterocíclico)metil)fenoxi)azetidin-1-il)(5-(fenil)-1,3,4-oxadiazol-2-il)metanona en el tratamiento de la obesidad? |
JP7185633B2 (ja) | 2017-02-17 | 2022-12-07 | トレベナ・インコーポレイテッド | 7員アザ複素環を含有するデルタ-オピオイド受容体調節化合物、その使用方法及び製造方法 |
EP3582779B1 (en) | 2017-02-17 | 2024-04-17 | Trevena, Inc. | 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN148482B (xx) | 1977-06-03 | 1981-03-07 | Pfizer | |
GB9321557D0 (en) | 1992-11-03 | 1993-12-08 | Zeneca Ltd | Carboxamide derivatives |
EP0714891A1 (en) * | 1994-11-22 | 1996-06-05 | Eli Lilly And Company | Heterocyclic tachykinin receptor antagonists |
JP4195512B2 (ja) | 1996-12-19 | 2008-12-10 | アベンティス・ファーマスーティカルズ・インコーポレイテッド | 新規な複素環置換ピロリジンアミド誘導体 |
CN1859914A (zh) * | 2003-09-30 | 2006-11-08 | 默克公司 | 苯基吡咯烷醚速激肽受体拮抗剂 |
US7138423B2 (en) * | 2004-07-20 | 2006-11-21 | Bristol-Myers Squibb Company | Arylpyrrolidine derivatives as NK-1 /SSRI antagonists |
EP1817302A4 (en) * | 2004-11-22 | 2009-07-01 | Merck & Co Inc | PIPERIDINYLPIPERIDIN-tachykinin receptor Antagonist |
CA2587195A1 (en) * | 2004-11-22 | 2006-07-13 | Merck & Co., Inc. | Cycloalkyl keto piperidine tachykinin receptor antagonists |
BRPI0815658A2 (pt) * | 2007-08-07 | 2015-02-18 | Hoffmann La Roche | Aril-éter pirrolidina como antagonistas do receptor nk3 |
-
2008
- 2008-08-12 JP JP2010521396A patent/JP2010536818A/ja active Pending
- 2008-08-12 CA CA2697325A patent/CA2697325A1/en not_active Abandoned
- 2008-08-12 CN CN200880103704A patent/CN101861302A/zh active Pending
- 2008-08-12 AU AU2008290634A patent/AU2008290634B2/en not_active Expired - Fee Related
- 2008-08-12 AT AT08787130T patent/ATE519738T1/de active
- 2008-08-12 BR BRPI0815674-3A2A patent/BRPI0815674A2/pt not_active IP Right Cessation
- 2008-08-12 EP EP08787130A patent/EP2190815B1/en not_active Not-in-force
- 2008-08-12 ES ES08787130T patent/ES2369955T3/es active Active
- 2008-08-12 RU RU2010108687/04A patent/RU2010108687A/ru not_active Application Discontinuation
- 2008-08-12 WO PCT/EP2008/060566 patent/WO2009024502A1/en active Application Filing
- 2008-08-12 MX MX2010001774A patent/MX2010001774A/es active IP Right Grant
- 2008-08-12 KR KR1020107006058A patent/KR101194467B1/ko not_active IP Right Cessation
- 2008-08-20 CL CL2008002450A patent/CL2008002450A1/es unknown
- 2008-08-21 PE PE2008001420A patent/PE20090621A1/es not_active Application Discontinuation
- 2008-08-21 US US12/195,545 patent/US7812021B2/en not_active Expired - Fee Related
- 2008-08-21 TW TW097131984A patent/TW200916462A/zh unknown
- 2008-08-21 AR ARP080103635A patent/AR067991A1/es unknown
-
2010
- 2010-02-16 ZA ZA201001125A patent/ZA201001125B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ES2369955T3 (es) | 2011-12-09 |
US20090054644A1 (en) | 2009-02-26 |
BRPI0815674A2 (pt) | 2015-02-18 |
KR101194467B1 (ko) | 2012-10-24 |
TW200916462A (en) | 2009-04-16 |
JP2010536818A (ja) | 2010-12-02 |
CN101861302A (zh) | 2010-10-13 |
KR20100043105A (ko) | 2010-04-27 |
CL2008002450A1 (es) | 2009-07-31 |
WO2009024502A1 (en) | 2009-02-26 |
EP2190815A1 (en) | 2010-06-02 |
RU2010108687A (ru) | 2011-09-27 |
PE20090621A1 (es) | 2009-05-16 |
AU2008290634A1 (en) | 2009-02-26 |
EP2190815B1 (en) | 2011-08-10 |
US7812021B2 (en) | 2010-10-12 |
AU2008290634B2 (en) | 2012-12-06 |
AR067991A1 (es) | 2009-10-28 |
ATE519738T1 (de) | 2011-08-15 |
CA2697325A1 (en) | 2009-02-26 |
MX2010001774A (es) | 2010-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201001125B (en) | Pyrrolidine Aryl-Ether as NK3 receptor antagonists | |
ZA201000676B (en) | Pyrrolidine aryl-ether as NK3 receptor antagonists | |
EP2244575A4 (en) | ANTAGONISTS OF THE ANGIOTENSIN II RECEPTOR | |
EP2214676A4 (en) | OXININE RECEPTOR ANTAGONISTS SUBSTITUTED DIAZEPAN TYPE | |
EP2150115A4 (en) | RECEPTOR ANTAGONISTS OF CYCLOPROPYLPYRROLIDINE OREXINE | |
EP2099454A4 (en) | AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR ANTAGONISTS | |
EP2001485A4 (en) | ANTAGONISTS OF OREXIN RECEPTORS IN THE FORM OF DIAZEPAN COMPOUNDS | |
HK1128691A1 (en) | Substituted diazepan compounds as orexin receptor antagonists | |
EP2203051A4 (en) | OCTAHYDROPENTAL COMPOUNDS AS CHEMOKIN RECEPTOR ANTAGONISTS | |
ZA201007126B (en) | Isoquinolinone derivatives as nk3 antagonists | |
EP2184278A4 (en) | P2X4 RECEIVER ANTAGONIST | |
IL201165A0 (en) | CRIg ANTAGONISTS | |
IL212545A0 (en) | Toll-like receptor 3 antagonists | |
ZA200903334B (en) | Substituted diazepan compounds as orexin receptor antagonists | |
IL213982A0 (en) | Piperidine derivatives as nk3 receptor antagonists | |
ZA201103119B (en) | Isoquinolinone derivatives as nk3 antagonists | |
IL212107A0 (en) | Isoquinolinone derivatives as nk3 antagonists | |
IL209663A0 (en) | Isoquinolinone derivatives as nk3 antagonists | |
IL207577A0 (en) | Pyrrolidine ether derivatives as nk3 receptor antagonists | |
IL209266A0 (en) | Pyrrolidine derivatives as nk2 receptor antagonists | |
IL217759A0 (en) | Pyrrolidine derivatives as nk3 receptor antagonists | |
EP2365748A4 (en) | IMIDAZOISOINDOLA ANTAGONISTS OF NEUROPEPTIDE S RECEPTORS | |
IL202454A0 (en) | Urotensin ii receptor antagonists | |
HK1169992A1 (en) | Pyrrolidine derivatives as nk - 3 receptor antagonists nk-3 | |
IL213763A0 (en) | Pyrrolidine derivatives as nk3 receptor antagonists |